Katia Scotlandi

Katia Scotlandi graduated in Biological Sciences at University of Bologna, Italy in 1986 and devoted her career to oncology research.
 Starting from specialization at the University of Bologna, she continued her training at the academic 
Rizzoli Institute, the main Italian center for bone sarcomas. She worked as visiting scientist at the University of Illinois at Chicago (1996) Kimmel Cancer Center Philadelphia (1999), INSERM Nice (2001) and University of Valencia (2009).

She is currently Acting Director of the SC Laboratory of Experimental Oncology, co-Director of the Oncology Research Line and member the Management Board of the at the Rizzoli Institute, Bologna Italy. 

She is also Secretary o the Working Group Sarcoma, Italian Alliance against Cancer (2016-present) and Adjunct Professor of Molecular Biology (2001-present) and she has mentoring for more than 70 students. She obtained the National Scientific Qualification for Full Professor in Applied Biology (05/F1); General and Clinical Pathology (06/A2); Molecular Biology (05/E2); Full Professor in Sciences of Health Professions and Applied Medical Technologies (06/N1).

From 2017, she is member of the Italian Top Women Scientists Committee. She served as President of the Italian Association of Cell Cultures from 2015-2018.
As reviewer, she is member of the Member of the Scientific Evaluation Committee of AIRC-FIRC Fellowships (2011-present) and of the International Translational/Clinical Cancer Research for French Ministry of Health and French National Cancer Institute-INCa (2011-present).

Her research is focused on focuses on discovering the players that control the malignancy of bone sarcomas, to define biomarkers of risk and best molecular therapeutic targets.
She awarded the “Oswald Van der Veken 2011”, Bruxelles, 2011 and the Tina Anselmi Award, Bologna (2019).

She co-authored 200 papers in international peer-review journals (H-index: 48, Scopus) and filed 3 patents (one recognized in Europe, USA and Canada and licenced to a private company).

Print Friendly, PDF & Email